FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns a method for prediction of relapse vulvar I and II stage. Proposed method consists in determining in tumour tissue a DNA of human papilloma virus by method of polymerase chain reaction. In the patients with stage I disease in the presence of virus, predict relapse by 57.3±0.3 months, in the absence of virus – through 36±0.12 months, in the patients with II stage of disease in the presence of virus occurrence of relapse is predicted through 48±0.2 months, while the absence of virus – through 27.1±0.08 months.
EFFECT: invention can be used in gynecology for prediction of recurrent carcinoma of vulva.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING COURSE OF TUMOUR PROCESS IN PATIENTS WITH VULVAR CANCER | 2015 |
|
RU2613119C1 |
| METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
| METHOD FOR RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN HPV 16-POSITIVE CERVICAL CANCER PATIENTS | 2018 |
|
RU2694834C1 |
| METHOD FOR PREDICTING NO RECURRENCE PERIOD AFTER HAVING APPLIED COMPLEX TREATMENT OF VULVA CANCER | 2001 |
|
RU2193776C1 |
| METHOD FOR REMISSION DURATION PREDICTION IN PATIENTS WITH VULVA CANCER | 2016 |
|
RU2624508C1 |
| METHOD OF FORECASTING RETROCESSIONS OF LARYNX CANCER | 2008 |
|
RU2389030C1 |
| METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
| METHOD FOR PREDICTION OF CERVICAL CANCER METASTASES | 2010 |
|
RU2436102C1 |
| METHOD FOR PREDICTING THE RISK OF RECURRENCE IN HPV16-POSITIVE PATIENTS WITH SQUAMOUS INTRAEPITHELIAL HIGH-GRADE DISEASE ON THE BASIS OF DETERMINING THE PHYSICAL STATUS OF THE VIRUS | 2019 |
|
RU2719581C1 |
| METHOD FOR PREDICTION OF RELAPSE DEVELOPMENT IN PATIENTS WITH ORAL MUCOSA CANCER | 2016 |
|
RU2635535C1 |
